Revolution Medicines $1 billion at-the-market offering
We advised the sales agent on the offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
RXO $400 million senior notes offering
We advised the representative of the initial purchasers on the offering
Averin Capital Acquisition $250 million IPO
We advised the underwriters on the IPO
AgomAb Therapeutics $200 million IPO
We advised the representatives of the several underwriters on the IPO
Perspective Therapeutics $175 million equity offering
We advised the representatives of the underwriters on the transaction
Vistra $2.25 billion secured notes offering
We advised the underwriters on the offering
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
OceanFirst Financial $225 million private placement
We are advising the placement agent on the transaction
Urban One capital raise and refinancing transaction
We advised an ad hoc group of noteholders on the transaction
Terns Pharmaceuticals $747.5 million stock offering
We advised the underwriters on the public offering